Eupraxia Pharmaceuticals is trading 5.1% down at $6.34 today as broader market weakness and risk-off sentiment weigh on the stock.
- Shares are retracing recent gains that followed bullish analyst coverage and financing momentum.
- The decline comes as major indices fall and investors rotate out of risk assets.
- No fresh company-specific news or catalysts have been identified to explain today's price action.